New strategies in fighting TB: Targeting Mycobacterium tuberculosis- secreted phosphatases MptpA & MptpB

Future Medicinal Chemistry

Volumn 2, Issue 8, 2010, Pages 1325-1337

  Silva, Ana Pg ^a   Tabernero, Lydia ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; BACTERIAL PROTEIN; BENZOFURAN SALICYLIC ACID; BENZOIC ACID DERIVATIVE; BRUNSVICAMIDE; CARBOXYLIC ACID DERIVATIVE; CHALCONE DERIVATIVE; CYCLODEPSIPEPTIDE; DIFLUOROMETHYLPHOSPHONIC ACID; INDOLIZINE DERIVATIVE; INDOLOQUINOLIZIDINE; ISOXAZOLE; ISOXAZOLE CARBOXYLIC ACID; MACROLINE; OXALYLAMINO METHYLENE THIOPHENE SULPHONAMIDE; PHOSPHONIC ACID DERIVATIVE; POLYKETIDE; PROTEIN MPTP A; PROTEIN MPTP B; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; QUINOLIZIDINE DERIVATIVE; SALICYLIC ACID DERIVATIVE; STEVASTELIN; SULFONAMIDE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PROTEIN TYROSINE PHOSPHATASES; TUBERCULOSIS;

EID: 77956032950     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.10.214     Document Type: Review

References (59)

1. Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134(3 Part 1), 713-740 (1971).
2. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat. Rev. Microbiol. 2(3), 189-202 (2004).
3. Pizarro-Cerda J, Cossart P. Subversion of phosphoinositide metabolism by intracellular bacterial pathogens. Nat. Cell Biol. 6(11), 1026-1033 (2004).
4. Hestvik AL, Hmama Z, Av-Gay Y. Mycobacterial manipulation of the host cell. FEMS Microbiol. Rev. 29(5), 1041-1050 (2005).
5. Weber SS, Ragaz C, Hilbi H. Pathogen trafficking pathways and host phosphoinositide metabolism. Mol. Microbiol. 71(6), 1341-1352 (2009).
6. Rosqvist R, Bolin I, Wolf-Watz H. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56(8), 2139-2143 (1988).
7. Bliska JB, Black DS. Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase. Infect. Immun. 63(2), 681-685 (1995).
8. Black DS, Bliska JB. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 16(10), 2730-2744 (1997).
9. Black DS, Marie-Cardine A, Schraven B, Bliska JB. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signaling complex in macrophages. Cell Microbiol. 2(5), 401-414 (2000).
10. Persson C, Carballeira N, Wolf-Watz H, Fallman M. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 16(9), 2307-2318 (1997).
11. Humphreys D, Hume PJ, Koronakis V. The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche. Cell Host Microbe 5(3), 225-233 (2009).
12. Kaniga K, Uralil J, Bliska JB, Galan JE. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21(3), 633-641 (1996).
13. Lin SL, Le TX, Cowen DS. SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation. Cell Microbiol. 5(4), 267-275 (2003).
14. Liang F, Huang Z, Lee SY et al. Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. J. Biol. Chem. 278(43), 41734-41741 (2003).
15. Walburger A, Koul A, Ferrari G et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304(5678), 1800-1804 (2004).
16. Papavinasasundaram KG, Chan B, Chung JH, Colston MJ, Davis EO, Av-Gay Y. Deletion of the Mycobacterium tuberculosis pknH gene confers a higher bacillary load during the chronic phase of infection in BALB/c mice. J. Bacteriol. 187(16), 5751-5760 (2005).
17. Bach H, Papavinasasundaram KG, Wong D, Hmama Z, Av-Gay Y. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3(5), 316-322 (2008).
18. Singh R, Rao V, Shakila H et al. Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol. Microbiol. 50(3), 751-762 (2003).
19. Wehenkel A, Bellinzoni M, Grana M et al. Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim. Biophys. Acta. 1784(1), 193-202 (2008).
20. Av-Gay Y, Alber T. Prospects for TB therapeutics targeting Mycobacterium tuberculosis phosphosignaling networks. In: Protein Kinases as Drug Targets, Müller G, Klebl B (Eds.), Wiley VCH, Germany (2009).
21. Beresford NJ, Mulhearn D, Szczepankiewicz B et al. Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages. J. Antimicrob. Chemother. 63(5), 928-936 (2009).
22. Zhou B, He Y, Zhang X et al. Targeting mycobacterium protein tyrosine phosphatase B for anti-tuberculosis agents. Proc. Natl Acad. Sci. USA 107(10), 4573-4578 (2010).
23. Boitel B, Ortiz-Lombardia M, Duran R et al. PknB kinase activity is regulated by phosphorylation in two Thr residues and dephosphorylation by PstP, the cognate phospho-Ser/Thr phosphatase, in Mycobacterium tuberculosis. Mol. Microbiol. 49(6), 1493-1508 (2003).
24. Chopra P, Singh B, Singh R et al. Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine-threonine kinases PknA and PknB. Biochem. Biophys. Res. Commun. 311(1), 112-120 (2003).
25. Koul A, Choidas A, Treder M et al. Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J. Bacteriol. 182(19), 5425-5432 (2000).
26. Castandet J, Prost JF, Peyron P et al. Tyrosine phosphatase MptpA of Mycobacterium tuberculosis inhibits phagocytosis and increases actin polymerization in macrophages. Res. Microbiol. 156(10), 1005-1013 (2005).
27. Grundner C, Cox JS, Alber T. Protein tyrosine phosphatase PtpA is not required for Mycobacterium tuberculosis growth in mice. FEMS Microbiol. Lett. 287(2), 181-184 (2008).
28. Madhurantakam C, Rajakumara E, Mazumdar PA et al. Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-A resolution. J. Bacteriol. 187(6), 2175-2181 (2005).
29. Zhang M, Stauffacher CV, Lin D, Van Etten RL. Crystal structure of a human low molecular weight phosphotyrosyl phosphatase. Implications for substrate specificity. J. Biol. Chem. 273(34), 21714-21720 (1998).
30. Hagelueken G, Huang H, Mainprize IL, Whitfield C, Naismith JH. Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly. J. Mol. Biol. 392(3), 678-688 (2009).
31. Xu H, Xia B, Jin C. Solution structure of a low-molecular-weight protein tyrosine phosphatase from Bacillus subtilis. J. Bacteriol. 188(4), 1509-1517 (2006).
32. Tolkatchev D, Shaykhutdinov R, Xu P et al. Three-dimensional structure and ligand interactions of the low molecular weight protein tyrosine phosphatase from Campylobacter jejuni. Protein Sci. 15(10), 2381-2394 (2006).
33. Zhang M, Zhou M, Van Etten RL, Stauffacher CV. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. Biochemistry 36(1), 15-23 (1997).
34. Beresford N, Patel S, Armstrong J, Szoor B, Fordham-Skelton AP, Tabernero L. MptpB, a virulence factor from Mycobacterium tuberculosis, exhibits triple-specificity phosphatase activity. Biochem. J. 406(1), 13-18 (2007).
35. Grundner C, Ng HL, Alber T. Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site. Structure 13(11), 1625-1634 (2005).
36. Grundner C, Perrin D, Hooft van Huijsduijnen R et al. Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure 15(4), 499-509 (2007).
37. Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc. Natl Acad. Sci. USA 94(25), 13420-13425 (1997).
38. Tan LP, Wu H, Yang PY et al. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. Org. Lett. 11(22), 5102-5105 (2009).
39. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7(11), 833-846 (2006).
40. Bialy L, Waldmann H. Inhibitors of protein tyrosine phosphatases: next-generation drugs? Angew. Chem. Int. Ed. Engl. 44(25), 3814-3839 (2005).
41. Manger M, Scheck M, Prinz H et al. Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) inhibitors based on natural products and a fragment-based approach. ChemBioChem. 6(10), 1749-1753 (2005).
42. Chiaradia LD, Mascarello A, Purificacao M et al. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg. Med. Chem. Lett. 18(23), 6227-6230 (2008).
43. Rawls KA, Lang PT, Takeuchi J et al. Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg. Med. Chem. Lett. 19(24), 6851-6854 (2009).
44. Weide T, Arve L, Prinz H, Waldmann H, Kessler H. 3-substituted indolizine-1- carbonitrile derivatives as phosphatase inhibitors. Bioorg. Med. Chem. Lett. 16(1), 59-63 (2006).
45. Noren-Muller A, Reis-Correa I Jr, Prinz H et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc. Natl Acad. Sci. USA 103(28), 10606-10611 (2006).
46. Seibert SF, Eguereva E, Krick A et al. Polyketides from the marine-derived fungus Ascochyta salicorniae and their potential to inhibit protein phosphatases. Org. Biomol. Chem. 4(11), 2233-2240 (2006).
47. Muller D, Krick A, Kehraus S et al. Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. J. Med. Chem. 49(16), 4871-4878 (2006).
48. Noren-Muller A, Wilk W, Saxena K, Schwalbe H, Kaiser M, Waldmann H. Discovery of a new class of inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B by biology-oriented synthesis. Angew. Chem. Int. Ed. Engl. 47(32), 5973-5977 (2008).
49. Soellner MB, Rawls KA, Grundner C, Alber T, Ellman JA. Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB. J. Am. Chem. Soc. 129(31), 9613-9615 (2007).
50. Liu G, Xin Z, Pei Z et al. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor. J. Med. Chem. 46(20), 4232-4235 (2003).
51. Liu G, Szczepankiewicz BG, Pei Z et al. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J. Med. Chem. 46(11), 2093-2103 (2003).
52. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6(1), 17-27 (2008).
53. Potterton L, McNicholas S, Krissinel E et al. Developments in the CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 60(Pt 12 Pt 1), 2288-2294 (2004).
54. Deprez C, Lloubes R, Gavioli M, Marion D, Guerlesquin F, Blanchard L. Solution structure of the E.coli TolA C-terminal domain reveals conformational changes upon binding to the phage g3p N-terminal domain. J. Mol. Biol. 346(4), 1047-1057 (2005).
55. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22(22), 4673-4680 (1994).
56. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9), 1189-1191 (2009).
57. Zhao H, Liu G, Xin Z et al. Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorg. Med. Chem. Lett. 14(22), 5543-5546 (2004).
58. World health Organization www.who.int
59. Dali Server http://ekhidna.biocenter.helsinki.fi/ dali-server/